Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTSupporting digestion and nutrient absorptionHill’s Prescription Diet i/d supports easy nutrient absorption through its highly digestible formula that cats will love. + Learn More